Day 2 President Presser On Data

April 2, 2021
Featured Article Image

For the second day, the President provided an update on the COVID-19 pandemic.

3 Highlights To Know

“Nationwide, beyond the outbreak in several states, cases remain low and very stable.”

Pres. Trump says the percentage of Americans testing positive for COVID-19 is declining and lower than in the spring. Meanwhile, California surpassed New York Wednesday as the state having had the most cases of COVID-19 in the nation (413,000+). Ohio, Minnesota & Indiana issued statewide mask mandates; the Pres. said a decision about mask requirements on federal property is coming in the next 24 hours.

“…we’re requiring increased testing of the nursing home personnel in states where you had the worst outbreaks.”

Pres. Trump said the federal government would distribute 15,000 rapid tests to nursing homes, calling the 5-15 minute tests "very accurate." *Separately,* The New England Journal of Medicine this week highlighted Congress allocating $1.5B for rapid, point-of-care COVID-19 testing with the hopes of being able to test 2% of the U.S. population, or 6 million people per day, by this fall.

“Our strategy is to shelter the highest-risk Americans, while allowing younger and healthier citizens to return to work or school while being careful and very vigilant. “

Pres. Trump repeated that more than half U.S. COVID deaths are attributed to a group that makes up less than 1% of the U.S. population: those in nursing homes or long-term care facilities. The President said he is "comfortable" letting his child/grandchildren go back to school.

The President said the U.S. gov't is looking carefully at how children transmit COVID-19 and to expect more information "over the next week." The President said the gov't secured doses of a potential vaccine, is focusing on therapeutics, and he remains hopeful for a "cure."

Here’s a link to the President’s press briefing: CLICK HERE

Here’s some info on the states requiring masks: CLICK HERE

New England Journal of Medicine on rapid testing: Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative

On April 24, 2020, Congress appropriated $1.5 billion, from the $25 billion provided in the Paycheck Protection Program and Health Care Enhancement Act for SARS-CoV-2 testing, to the NIH. Within 5 days after the legislation was signed into law, the NIH launched RADx to support the development, production scale-up, and deployment of accurate, rapid tests across the country. From a timing perspective, the RADx initiative was conceived by Congress to provide near-term solutions to increase the number of tests available by the fall of 2020, as schools and universities evaluate the safety of in-person classes and as the annual influenza season begins. In the slightly longer term, RADx also aims to support the development and production of innovative diagnostic technologies as well as strategies for making testing available to diverse, vulnerable, and underserved populations through 2021. One of the goals of the RADx initiative is to expand capacity so that by December 2020, approximately 2% of the U.S. population (6 million persons) can be tested per day, with more tests ready for rapid deployment in proportion to national demand.

by Jenna Lee,